← Back to Search

Quality Improvement Evaluation for Diabetes

N/A
Waitlist Available
Led By Marshall Chin, MD, MPH
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline data will be collected at the end of 1st year; follow-up data will be collected from years 2-7.
Awards & highlights

Study Summary

The Improving Diabetes Care and Outcomes project aims to reduce diabetes disparities and engages patients, providers, clinics, and community collaborators to improve the health care and outcomes of African-Americans on the South Side of Chicago. Initiated in 2009, this project is a collaborative, community-based intervention that employs a multifaceted, integrated approach to address many of the root causes of health disparities. The short-term goal of this project is to improve clinic processes such as appointment scheduling and patient counseling through quality improvement efforts, as well as clinical outcomes including HbA1c, cholesterol and blood pressure in patients with diabetes through patient education. Long-term goals are to strengthen the network of community health centers, community-based organizations and academic medical centers, while increasing awareness of local diabetes disparities and empowering communities to combat this problem.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline data will be collected at the end of 1st year; follow-up data will be collected from years 2-7.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline data will be collected at the end of 1st year; follow-up data will be collected from years 2-7. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood pressure
HbA1c
Lipids (HDL, LDL, total cholesterol, triglycerides)
Secondary outcome measures
Processes of care

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Group I: Quality Improvement EvaluationExperimental Treatment1 Intervention
We measure quality improvement efforts through biannual staff experience surveys and one-on-one provider and clinic staff interviews.
Group II: Provider Training EvaluationExperimental Treatment1 Intervention
Pre-post surveys are conducted at each training session to assess overall satisfaction with the curriculum, knowledge of SDM, and understanding of techniques to promote its use in the healthcare setting.
Group III: Patient ActivationExperimental Treatment1 Intervention
Patient knowledge in diabetes self-management behaviors and clinical measures (HbA1c, LDL, HDL, BMI, BP) are tracked at baseline, 10-weeks (post-program), 3 months (post-program) and 6 months (post-program).
Group IV: Community Outreach EvaluationExperimental Treatment1 Intervention
Pre-post surveys will be disseminated at nutrition tours (Save-A-Lot, Walgreens, 61st Street Farmers Market) to assess change in knowledge of healthy eating behaviors and proper nutrition. Surveys will also assess participant satisfaction of the tours. Interviews will also be performed with community stakeholders to assess the costs/benefits of the collaboration and overall feedback on involvement.
Group V: Global Evaluation of the InterventionActive Control1 Intervention
A chart review will be performed in order to evaluate our intervention to improve diabetes processes of care and clinical outcomes among our target population. Chart abstractions will be performed on medical records obtained from our six intervention clinics. In addition, chart abstractions from two University of Illinois at Chicago clinics and three FQHCs located on the West Side of Chicago will serve as control data.100 charts will be randomly selected from each clinic per year of the intervention. The chart review will contain charts from adult diabetes patients over a seven year period that matches the duration of the Improving Diabetes project.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Community Outreach
2009
N/A
~6210
Quality Improvement
2014
N/A
~13790
Patient Activation
2009
N/A
~6210
Provider Training
2013
N/A
~6800

Find a Location

Who is running the clinical trial?

Merck Sharp & Dohme LLCIndustry Sponsor
3,888 Previous Clinical Trials
5,053,726 Total Patients Enrolled
15 Trials studying Diabetes
107,302 Patients Enrolled for Diabetes
University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
813,568 Total Patients Enrolled
12 Trials studying Diabetes
7,691 Patients Enrolled for Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,309,286 Total Patients Enrolled
107 Trials studying Diabetes
138,663 Patients Enrolled for Diabetes

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Medical Care Research and ReviewJournal
Diabetes Health Disparities
Peek, Monica E., Algernon Cargill, and Elbert S. Huang. 2007. “Diabetes Health Disparities”. Medical Care Research and Review. SAGE Publications. doi:10.1177/1077558707305409.
clinicaltrials.govStudy
Improving Diabetes Care and Outcomes on the South Side of Chicago
2009. "Improving Diabetes Care and Outcomes on the South Side of Chicago". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01087073.
~382 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top